| 2017 ESC guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European Society for Vascular Surgery (ESVS) V Aboyans, JB Ricco, ML Bartelink, M Björck, M Brodmann, T Cohner, ... Polish Heart Journal (Kardiologia Polska) 75 (11), 1065-1160, 2017 | 5199* | 2017 |
| Leptin-regulated endocannabinoids are involved in maintaining food intake V Di Marzo, SK Goparaju, L Wang, J Liu, S Bátkai, Z Járai, F Fezza, ... Nature 410 (6830), 822-825, 2001 | 2024 | 2001 |
| 2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension: Endorsed by … G Mancia, R Kreutz, M Brunström, M Burnier, G Grassi, A Januszewicz, ... Journal of hypertension 41 (12), 1874-2071, 2023 | 1875 | 2023 |
| Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial SS Anand, J Bosch, JW Eikelboom, SJ Connolly, R Diaz, P Widimsky, ... The Lancet 391 (10117), 219-229, 2018 | 997 | 2018 |
| European Society of Cardiology: cardiovascular disease statistics 2021 A Timmis, P Vardas, N Townsend, A Torbica, H Katus, D De Smedt, ... European heart journal 43 (8), 716-799, 2022 | 890 | 2022 |
| Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors Z Járai, JA Wagner, K Varga, KD Lake, DR Compton, BR Martin, ... Proceedings of the National Academy of Sciences 96 (24), 14136-14141, 1999 | 746 | 1999 |
| Endocannabinoids acting at vascular CB1 receptors mediate the vasodilated state in advanced liver cirrhosis S Bátkai, Z Járai, JA Wagner, SK Goparaju, KÁ Varga, J Liu, L Wang, ... Nature medicine 7 (7), 827-832, 2001 | 471 | 2001 |
| Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial SJ Connolly, JW Eikelboom, J Bosch, G Dagenais, L Dyal, F Lanas, ... The Lancet 391 (10117), 205-218, 2018 | 412 | 2018 |
| Mesenteric vasodilation mediated by endothelial anandamide receptors JA Wagner, K Varga, Z Járai, G Kunos Hypertension 33 (1), 429-434, 1999 | 323 | 1999 |
| Sympathetic and baroreceptor reflex function in neurally mediated syncope evoked by tilt. R Mosqueda-Garcia, R Furlan, R Fernandez-Violante, T Desai, M Snell, ... The Journal of clinical investigation 99 (11), 2736-2744, 1997 | 304 | 1997 |
| May Measurement Month 2018: a pragmatic global screening campaign to raise awareness of blood pressure by the International Society of Hypertension T Beaney, LM Burrell, RR Castillo, FJ Charchar, S Cro, A Damasceno, ... European heart journal 40 (25), 2006-2017, 2019 | 282 | 2019 |
| Hemodynamic effects of cannabinoids: coronary and cerebral vasodilation mediated by cannabinoid CB1 receptors JA Wagner, Z Járai, S Bátkai, G Kunos European journal of pharmacology 423 (2-3), 203-210, 2001 | 220 | 2001 |
| Endocannabinoids as cardiovascular modulators G Kunos, Z Járai, S Bátkai, SK Goparaju, EJN Ishac, J Liu, L Wang, ... Chemistry and physics of lipids 108 (1-2), 159-168, 2000 | 195 | 2000 |
| Non-invasive assessment of microvascular endothelial function by laser Doppler flowmetry in patients with essential hypertension K Farkas, E Kolossváry, Z Járai, J Nemcsik, C Farsang Atherosclerosis 173 (1), 97-102, 2004 | 180 | 2004 |
| Cardiovascular effects of 2-arachidonoyl glycerol in anesthetized mice Z Járai, JA Wagner, SK Goparaju, L Wang, RK Razdan, T Sugiura, ... Hypertension 35 (2), 679-684, 2000 | 124 | 2000 |
| Hemodynamic profile, responsiveness to anandamide, and baroreflex sensitivity of mice lacking fatty acid amide hydrolase P Pacher, S Bátkai, D Osei-Hyiaman, L Offertáler, J Liu, J Harvey-White, ... American Journal of Physiology-Heart and Circulatory Physiology 289 (2 …, 2005 | 92 | 2005 |
| Trends in major lower limb amputation related to peripheral arterial disease in Hungary: a nationwide study (2004–2012) E Kolossváry, T Ferenci, T Kováts, L Kovács, Z Járai, G Menyhei, K Farkas European Journal of Vascular and Endovascular Surgery 50 (1), 78-85, 2015 | 90 | 2015 |
| Cannabinoid antagonist SR-141716 inhibits endotoxic hypotension by a cardiac mechanism not involving CB1 or CB2 receptors S Bátkai, P Pacher, Z Járai, JA Wagner, G Kunos American Journal of Physiology-Heart and Circulatory Physiology 287 (2 …, 2004 | 87 | 2004 |
| Authors/Task Force Members. 2023 ESH Guidelines for the management of arterial hypertension. The Task Force for the management of arterial hypertension of the European Society … G Mancia, R Kreutz, M Brunström, M Burnier, G Grassi, A Januszewicz, ... J Hypertens 41 (12), 1874-2071, 2023 | 83 | 2023 |
| Optimal use of lipid-lowering therapy after acute coronary syndromes: A Position Paper endorsed by the International Lipid Expert Panel (ILEP) M Banach, PE Penson, M Vrablik, M Bunc, K Dyrbus, J Fedacko, D Gaita, ... Pharmacological research 166, 105499, 2021 | 76 | 2021 |
